We are the experts in rat fertility control. Our passion is to create a healthy environment by better controlling rat pest populations. We keep an inescapable truth in mind. Two rats and their descendants can be responsible for the birth of up to 15,000 pups after a...
SenesTech to Participate in the Lytham Partners Investor Select Conference
PHOENIX, Jan. 24, 2023 -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today announced the management team will present and host one-on-one meetings with investors at...
SenesTech Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PHOENIX, Dec. 20, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today reported the grant...
SenesTech, Inc. Announces Closing of $5 Million Public Offering
PHOENIX, Nov. 18, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
SenesTech, Inc. Announces Pricing of $5 Million Public Offering
PHOENIX, Nov. 16, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
SenesTech Announces Reverse Stock Split
Common Stock Will Begin Trading on a Split-Adjusted Basis on November 16, 2022 PHOENIX, Nov. 15, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company") (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
SenesTech Announces Third Quarter 2022 Financial Results
Product Sales up 57% year-over-year PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats,...
SenesTech Announces Appointment of Vector and Pest Control Industry Veteran Joel Fruendt as Chief Executive Officer
PHOENIX, Nov. 14, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced the...
SenesTech to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022
Financial results to be released before market open; Conference call to be conducted at 11:00 am ET PHOENIX, Nov. 9, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2022, ended September 30, 2022, before the market open on...
SenesTech, Inc. (SNES) Fireside Chat
Today we welcome SenesTech, ticker of SNES on the NASDAQ, and their Chief Executive Officer, Ken Siegel; and Chief Financial Officer, Tom Chesterman. SenesTech is the leader in fertility control to manage animal pest populations This Fireside Chat was recorded during...